Baron Health Care Fund Q4 2025 Contributors And Detractors [Seeking Alpha]
Is It Time To Reassess Doximity (DOCS) After A 62.5% One Year Slide? [Yahoo! Finance]
Doximity (NASDAQ:DOCS) had its price target lowered by analysts at JPMorgan Chase & Co. from $40.00 to $33.00. They now have a "neutral" rating on the stock.
Doximity (NASDAQ:DOCS) had its price target raised by analysts at Piper Sandler from $40.00 to $42.00. They now have an "overweight" rating on the stock.
Halper Sadeh LLC Encourages Doximity Inc. Shareholders to Contact the Firm to Discuss Their Rights